Controlled Release Systems

Pharmaceutical markets in the US and EU prefer once daily, ideally one tablet/capsule per dose, drug products.

Controlled release technologies could help those molecules with short in vivo half life, potentially achieving once daily use.

Many pharmaceutically active ingredients from botanical medicines have short in vivo half-lives

Technologies including matrix tablet, film coating, osmotic tablet, particle processing, etc, could provide controlled release profiles.

 




Tel: +86-755-86007001   Email: info@hlkpharma.com